HROWHarrow Health, Inc.

$1B

Q4 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$89M+33.3% YoY

Gross Profit

$71M79.3% margin

Operating Income

$16M17.5% margin

Net Income

$7M7.4% margin

EPS (Diluted)

$0.18

QoQ Revenue Growth

+24.4%

Cash Flow

Operating Cash Flow

$39M

Free Cash Flow

$38M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$399M

Total Liabilities

$347M

Stockholders' Equity

$52M

Cash & Equivalents

$73M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$89M	$67M	+33.3%
Gross Profit	$71M	$53M	+34.0%
Operating Income	$16M	$13M	+20.9%
Net Income	$7M	$7M	-2.2%

HROW Q4 2025 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena